Uncovering July 2024's Undiscovered Gems In India
In This Article:
The Indian market has experienced a mix of dynamics recently, with a 1.5% decline over the last week contrasting sharply against a robust annual growth of 44%. In this context, identifying stocks that not only have strong fundamentals but also the potential for significant earnings growth becomes particularly compelling.
Top 10 Undiscovered Gems With Strong Fundamentals In India
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Deep Industries | 10.38% | 10.66% | 28.71% | ★★★★★★ |
| ELANTAS Beck India | NA | 14.47% | 23.78% | ★★★★★★ |
| Om Infra | 13.99% | 43.48% | 23.30% | ★★★★★☆ |
| Alembic | 0.42% | 11.74% | -6.39% | ★★★★★☆ |
| Indo Tech Transformers | 2.30% | 20.60% | 62.92% | ★★★★★☆ |
| Avantel | 10.67% | 34.84% | 36.61% | ★★★★★☆ |
| Spright Agro | 0.58% | 83.13% | 86.22% | ★★★★★☆ |
| KP Green Engineering | 13.73% | 47.60% | 61.28% | ★★★★★☆ |
| Vasa Denticity | 0.11% | 38.86% | 55.93% | ★★★★☆☆ |
| Apollo Micro Systems | 38.17% | 7.94% | 2.46% | ★★★★☆☆ |
Let's dive into some prime choices out of from the screener.
Network People Services Technologies
Simply Wall St Value Rating: ★★★★★☆
Overview: Network People Services Technologies Limited specializes in creating digital payment solutions for banks, financial institutions, and merchants within the fintech sector in India, with a market capitalization of ?46.44 billion.
Operations: The company generates revenue through the sale of products and services, consistently reflecting a gross profit margin increase over the years, notably from 51.64% in 2018 to over 40% by mid-2024. This growth trajectory is supported by managing operating and non-operating expenses effectively while expanding its revenue base significantly, reaching ?1.63 billion by June 2024.
Network People Services Technologies (NPST) showcases a compelling growth trajectory, with earnings surging by 222.5% over the past year, significantly outpacing the diversified financial industry's growth of 21.3%. This performance is underpinned by robust financial health, evidenced by its debt to equity ratio of just 0.2%, and an EBIT coverage for interest payments at a strong 2279.1 times. Recent strategic moves include securing a major contract for a mobile banking solution, enhancing digital accessibility in rural banks—further solidifying its market position as an emerging gem in India’s financial sector.
-
Take a closer look at Network People Services Technologies' potential here in our health report.
-
Understand Network People Services Technologies' track record by examining our Past report.
Orchid Pharma
Simply Wall St Value Rating: ★★★★★★
Overview: Orchid Pharma Limited is a pharmaceutical company based in India that specializes in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals, with a market capitalization of ?69.78 billion.